Insider Trading History of O'neil Thomas P.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by O'neil Thomas P. since 2017. The trader's CIK number is 1640645. At the time of the last reporting, O'neil Thomas P. was the Chief Financial Officer of Satsuma Pharmaceuticals, Inc.. (stock ticker symbol STSA). Also see all insider trading activities at Satsuma Pharmaceuticals, Inc..

Note that in the past O'Neil Thomas P. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Satsuma Pharmaceuticals, Inc. (STSA) by O'neil Thomas P.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 STSA 0 $0 8,865 $245,800 8,865 $32,978

Yearly summary of insider trading at Protagonist Therapeutics, Inc (PTGX) by O'neil Thomas P.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 PTGX 0 $0 8,000 $160,000 8,000 $21,480


Insider trading activities at 2 companies by O'neil Thomas P.:

1. Satsuma Pharmaceuticals, Inc. (STSA)

2. Protagonist Therapeutics, Inc (PTGX)

Table 1. Insider trading of Satsuma Pharmaceuticals, Inc. (STSA) by O'neil Thomas P.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-09-01 STSA Sale 750 22.19 16,644
2020-09-01 STSA Option Ex 750 4.56 3,419
2020-08-05 STSA Option Ex 1,000 4.56 4,560
2020-08-05 STSA Sale 1,000 25.00 25,000
2020-07-01 STSA Option Ex 1,000 4.56 4,560
2020-07-01 STSA Sale 1,000 26.64 26,643
2020-06-23 STSA Sale 2,115 35.23 74,511
2020-06-23 STSA Option Ex 2,115 1.04 2,199
2020-06-01 STSA Option Ex 1,000 4.56 4,560
2020-06-01 STSA Sale 1,000 25.32 25,324
2020-05-20 STSA Option Ex 2,000 4.56 9,120
2020-05-20 STSA Sale 2,000 25.00 50,000
2020-03-11 STSA Option Ex 1,000 4.56 4,560
2020-03-11 STSA Sale 1,000 27.68 27,678

Table 2. Insider trading of Protagonist Therapeutics, Inc (PTGX) by O'neil Thomas P.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-12-18 PTGX Option Ex 8,000 2.69 21,480
2017-12-18 PTGX Sale 8,000 20.00 160,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by O'neil Thomas P. (Chief Financial Officer of Satsuma Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.